Skip to content

Preemptive Analgesia of Celecoxib in Mandibular Impacted Tooth Extraction

Preemptive Analgesia of Celecoxib in Mandibular Impacted Tooth Extraction

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500095808
Enrollment
Unknown
Registered
2025-01-13
Start date
2025-01-21
Completion date
Unknown
Last updated
2025-01-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None

Interventions

Experimental group :In the experimental group, patients took 200mg of celecoxib capsules orally 30 minutes before the operation.
Control group:In the control group, patients took 300mg of ibuprofen sustained-release capsules orally 30 minutes before the operation.

Sponsors

Beijing Shijingshan Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 40 Years

Inclusion criteria

Inclusion criteria: 1. Adult males and females aged between 18 and 40 years, with good physical health and no systemic diseases. 2. Patients with mandibular third molars that are mesioangularly impacted according to the Pell & Gregoey classification and mesially impacted according to the Winter classification, requiring gingival incision, flap elevation, bone removal, crown removal or root amputation. 3. With no history of allergy to non-steroidal anti-inflammatory drugs and acetaminophen. 4. Having not taken painkillers, anti-inflammatory drugs or anticoagulants within one week before tooth extraction. 5. The operation is completed within 30 - 40 minutes. 6. The patient signs the informed consent form.

Exclusion criteria

Exclusion criteria: 1. There are dental caries, periapical periodontitis, periodontitis or alveolar osteitis in the mandibular third molars and their adjacent teeth. 2. There are contraindications affecting tooth extraction, such as cardiovascular and cerebrovascular diseases, liver diseases and kidney diseases. 3. Non-experimental drugs are used for analgesia or anti-inflammation after tooth extraction. 4. There is a history of peptic ulcer or bleeding. 5. Special populations, including pregnant women, lactating women or patients with mental disorders.

Design outcomes

Primary

MeasureTime frame
Pain scores;The usage situation of emergency analgesic drugs.;

Secondary

MeasureTime frame
Adverse Reaction Incidence Rate;MDAS score;

Countries

China

Contacts

Public ContactMa Weiqing

Beijing Shijingshan Hospital

2473350170@qq.com+86 131 6187 0807

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026